17-AAG ≥98% HSP90 inhibitor
About this item
Potent, selective HSP90 inhibitor (IC₅₀ =5 nM). Anticancer activity, including cytostatic, proapoptotic and antiangiogenic properties in vitroand in vivo.
Caution: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.
- CAS Number:75747-14-7
- Molecular Weight:585,7 g/mol
2 Options Available Below
Product Details & Documents
Potent, selective HSP90 inhibitor (IC₅₀ =5 nM). Anticancer activity, including cytostatic, proapoptotic and antiangiogenic properties in vitroand in vivo.
Caution: All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.
- CAS Number:75747-14-7
- Molecular Weight:585,7 g/mol
Specifications for Product Family
Specification Test Results
- Constituents::100% Tanespimycin (17-AAG)